Predatory journals in guidelines, fraudulent data and error, research integrity

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F22%3A00126839" target="_blank" >RIV/00216224:14110/22:00126839 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Predatory journals in guidelines, fraudulent data and error, research integrity

Original language description

Background Robust and trustworthy systematic reviews (and other evidence synthesis products) are essential to inform policy, legislation and clinical decision making. However, the mass production of predatory journals and the proliferation of questionable or fraudulent research presents serious challenges to the validity and trustworthiness of systematic reviews. There is evidence that studies from predatory journals are infiltrating major medical databases and being included in systematic reviews. The amount of predatory journals and dubious research continues to expand, we need to turn our attention to how we protect systematic reviewers, guideline developers, policy makers and clinicians from this deluge of poor evidence. Objective This panel will focus on issues related to predatory journals, error and fraudulent research. There will be a number of short presentations followed by question and answers and a moderated panel discussion. The session will close with establishing a list of research priorities, where guidance is needed and remaining unanswered questions to inform a targeted research agenda. Content of presentations 1. An introduction and overview of predatory journals, error and fraud in science 2. Whether to include (or not) studies from predatory journals in systematic reviews and guidelines: an overview and interim guidance 3. Searching systematically and predatory journals 4. What are we currently doing with studies from predatory journals: results of focus groups and surveys of guideline developers and systematic reviewers 5. What to do about error, fraud and retracted

Czech name

—

Czech description

—

Type

O - Miscellaneous

CEP classification

—

OECD FORD branch

30230 - Other clinical medicine subjects

Project

<a href="/en/project/LTC20031" target="_blank" >LTC20031: Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2022

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů